Release 4 5 Preview #1

This page is part of the FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ) in it's permanent home (it will always be available at this URL). (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

4.4.1.234 4.4.1.247 Value Set http://hl7.org/fhir/ValueSet/vaccine-code

Public Health and Emergency Response Work Group   Maturity Level : 1 Draft Use Context : Any

This is a value set defined by the FHIR project.

Summary

Defining URL: http://hl7.org/fhir/ValueSet/vaccine-code
Version: 4.0.1 4.2.0
Name: VaccineAdministeredValueSet
Title: Vaccine Administered Value Set
Definition:

This identifies the vaccine substance administered - CVX codes.

Committee: Public Health and Emergency Response Work Group
OID: 2.16.840.1.113883.3.88.12.80.22 (for OID based terminology systems)
Source Resource XML / JSON

This value set is used in the following places:

4.4.1.234.1 4.4.1.247.1 Content Logical Definition

This value set includes codes from the following code systems:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx
  • Include all codes defined in urn:oid:1.2.36.1.2001.1005.17

 

4.4.1.234.2 4.4.1.247.2 Expansion

This expansion generated 01 Nov 31 Dec 2019

This value set contains 268 concepts

Code System Display
143 http://hl7.org/fhir/sid/cvx Adenovirus types 4 and 7
54 http://hl7.org/fhir/sid/cvx adenovirus, type 4
55 http://hl7.org/fhir/sid/cvx adenovirus, type 7
82 http://hl7.org/fhir/sid/cvx adenovirus, unspecified formulation
24 http://hl7.org/fhir/sid/cvx anthrax
181 http://hl7.org/fhir/sid/cvx anthrax immune globulin
801 http://hl7.org/fhir/sid/cvx AS03 Adjuvant
19 http://hl7.org/fhir/sid/cvx BCG
27 http://hl7.org/fhir/sid/cvx botulinum antitoxin
173 http://hl7.org/fhir/sid/cvx cholera, BivWC
174 http://hl7.org/fhir/sid/cvx cholera, live attenuated
26 http://hl7.org/fhir/sid/cvx cholera, unspecified formulation
172 http://hl7.org/fhir/sid/cvx cholera, WC-rBS
29 http://hl7.org/fhir/sid/cvx CMVIG
56 http://hl7.org/fhir/sid/cvx dengue fever
12 http://hl7.org/fhir/sid/cvx diphtheria antitoxin
28 http://hl7.org/fhir/sid/cvx DT (pediatric)
20 http://hl7.org/fhir/sid/cvx DTaP
106 http://hl7.org/fhir/sid/cvx DTaP, 5 pertussis antigens
107 http://hl7.org/fhir/sid/cvx DTaP, unspecified formulation
146 http://hl7.org/fhir/sid/cvx DTaP,IPV,Hib,HepB
110 http://hl7.org/fhir/sid/cvx DTaP-Hep B-IPV
50 http://hl7.org/fhir/sid/cvx DTaP-Hib
120 http://hl7.org/fhir/sid/cvx DTaP-Hib-IPV
130 http://hl7.org/fhir/sid/cvx DTaP-IPV
132 http://hl7.org/fhir/sid/cvx DTaP-IPV-HIB-HEP B, historical
170 http://hl7.org/fhir/sid/cvx DTAP/IPV/HIB - non-US
01 http://hl7.org/fhir/sid/cvx DTP
22 http://hl7.org/fhir/sid/cvx DTP-Hib
102 http://hl7.org/fhir/sid/cvx DTP-Hib-Hep B
57 http://hl7.org/fhir/sid/cvx hantavirus
30 http://hl7.org/fhir/sid/cvx HBIG
52 http://hl7.org/fhir/sid/cvx Hep A, adult
154 http://hl7.org/fhir/sid/cvx Hep A, IG
169 http://hl7.org/fhir/sid/cvx Hep A, live attenuated
83 http://hl7.org/fhir/sid/cvx Hep A, ped/adol, 2 dose
84 http://hl7.org/fhir/sid/cvx Hep A, ped/adol, 3 dose
31 http://hl7.org/fhir/sid/cvx Hep A, pediatric, unspecified formulation
85 http://hl7.org/fhir/sid/cvx Hep A, unspecified formulation
104 http://hl7.org/fhir/sid/cvx Hep A-Hep B
193 http://hl7.org/fhir/sid/cvx Hep A-Hep B, pediatric/adolescent
08 http://hl7.org/fhir/sid/cvx Hep B, adolescent or pediatric
42 http://hl7.org/fhir/sid/cvx Hep B, adolescent/high risk infant
43 http://hl7.org/fhir/sid/cvx Hep B, adult
44 http://hl7.org/fhir/sid/cvx Hep B, dialysis
45 http://hl7.org/fhir/sid/cvx Hep B, unspecified formulation
58 http://hl7.org/fhir/sid/cvx Hep C
59 http://hl7.org/fhir/sid/cvx Hep E
189 http://hl7.org/fhir/sid/cvx HepB-CpG
60 http://hl7.org/fhir/sid/cvx herpes simplex 2
47 http://hl7.org/fhir/sid/cvx Hib (HbOC)
46 http://hl7.org/fhir/sid/cvx Hib (PRP-D)
49 http://hl7.org/fhir/sid/cvx Hib (PRP-OMP)
48 http://hl7.org/fhir/sid/cvx Hib (PRP-T)
17 http://hl7.org/fhir/sid/cvx Hib, unspecified formulation
51 http://hl7.org/fhir/sid/cvx Hib-Hep B
61 http://hl7.org/fhir/sid/cvx HIV
118 http://hl7.org/fhir/sid/cvx HPV, bivalent
62 http://hl7.org/fhir/sid/cvx HPV, quadrivalent
137 http://hl7.org/fhir/sid/cvx HPV, unspecified formulation
165 http://hl7.org/fhir/sid/cvx HPV9
86 http://hl7.org/fhir/sid/cvx IG
14 http://hl7.org/fhir/sid/cvx IG, unspecified formulation
87 http://hl7.org/fhir/sid/cvx IGIV
160 http://hl7.org/fhir/sid/cvx Influenza A monovalent (H5N1), ADJUVANTED-2013
151 http://hl7.org/fhir/sid/cvx influenza nasal, unspecified formulation
123 http://hl7.org/fhir/sid/cvx influenza, H5N1-1203
135 http://hl7.org/fhir/sid/cvx Influenza, high dose seasonal
153 http://hl7.org/fhir/sid/cvx Influenza, injectable, MDCK, preservative free
171 http://hl7.org/fhir/sid/cvx Influenza, injectable, MDCK, preservative free, quadrivalent
186 http://hl7.org/fhir/sid/cvx Influenza, injectable, MDCK, quadrivalent, preservative
158 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent
150 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent, preservative free
161 http://hl7.org/fhir/sid/cvx Influenza, injectable,quadrivalent, preservative free, pediatric
166 http://hl7.org/fhir/sid/cvx influenza, intradermal, quadrivalent, preservative free
111 http://hl7.org/fhir/sid/cvx influenza, live, intranasal
149 http://hl7.org/fhir/sid/cvx influenza, live, intranasal, quadrivalent
155 http://hl7.org/fhir/sid/cvx influenza, recombinant, injectable, preservative free
185 http://hl7.org/fhir/sid/cvx influenza, recombinant, quadrivalent,injectable, preservative free
141 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable
140 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable, preservative free
144 http://hl7.org/fhir/sid/cvx influenza, seasonal, intradermal, preservative free
15 http://hl7.org/fhir/sid/cvx influenza, split (incl. purified surface antigen)
168 http://hl7.org/fhir/sid/cvx influenza, trivalent, adjuvanted
88 http://hl7.org/fhir/sid/cvx influenza, unspecified formulation
16 http://hl7.org/fhir/sid/cvx influenza, whole
10 http://hl7.org/fhir/sid/cvx IPV
134 http://hl7.org/fhir/sid/cvx Japanese Encephalitis IM
39 http://hl7.org/fhir/sid/cvx Japanese encephalitis SC
129 http://hl7.org/fhir/sid/cvx Japanese Encephalitis, unspecified formulation
63 http://hl7.org/fhir/sid/cvx Junin virus
64 http://hl7.org/fhir/sid/cvx leishmaniasis
65 http://hl7.org/fhir/sid/cvx leprosy
66 http://hl7.org/fhir/sid/cvx Lyme disease
04 http://hl7.org/fhir/sid/cvx M/R
67 http://hl7.org/fhir/sid/cvx malaria
05 http://hl7.org/fhir/sid/cvx measles
68 http://hl7.org/fhir/sid/cvx melanoma
191 http://hl7.org/fhir/sid/cvx meningococcal A polysaccharide (non-US)
192 http://hl7.org/fhir/sid/cvx meningococcal AC polysaccharide (non-US)
108 http://hl7.org/fhir/sid/cvx meningococcal ACWY, unspecified formulation
163 http://hl7.org/fhir/sid/cvx meningococcal B, OMV
162 http://hl7.org/fhir/sid/cvx meningococcal B, recombinant
164 http://hl7.org/fhir/sid/cvx meningococcal B, unspecified
103 http://hl7.org/fhir/sid/cvx meningococcal C conjugate
148 http://hl7.org/fhir/sid/cvx Meningococcal C/Y-HIB PRP
147 http://hl7.org/fhir/sid/cvx meningococcal MCV4, unspecified formulation
136 http://hl7.org/fhir/sid/cvx Meningococcal MCV4O
114 http://hl7.org/fhir/sid/cvx meningococcal MCV4P
32 http://hl7.org/fhir/sid/cvx meningococcal MPSV4
167 http://hl7.org/fhir/sid/cvx meningococcal, unknown serogroups
03 http://hl7.org/fhir/sid/cvx MMR
94 http://hl7.org/fhir/sid/cvx MMRV
07 http://hl7.org/fhir/sid/cvx mumps
127 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09
128 http://hl7.org/fhir/sid/cvx Novel Influenza-H1N1-09, all formulations
125 http://hl7.org/fhir/sid/cvx Novel Influenza-H1N1-09, nasal
126 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09, preservative-free
02 http://hl7.org/fhir/sid/cvx OPV
179 http://hl7.org/fhir/sid/cvx OPV ,monovalent, unspecified
178 http://hl7.org/fhir/sid/cvx OPV bivalent
182 http://hl7.org/fhir/sid/cvx OPV, Unspecified
69 http://hl7.org/fhir/sid/cvx parainfluenza-3
177 http://hl7.org/fhir/sid/cvx PCV10
11 http://hl7.org/fhir/sid/cvx pertussis
23 http://hl7.org/fhir/sid/cvx plague
133 http://hl7.org/fhir/sid/cvx Pneumococcal conjugate PCV 13
100 http://hl7.org/fhir/sid/cvx pneumococcal conjugate PCV 7
152 http://hl7.org/fhir/sid/cvx Pneumococcal Conjugate, unspecified formulation
33 http://hl7.org/fhir/sid/cvx pneumococcal polysaccharide PPV23
109 http://hl7.org/fhir/sid/cvx pneumococcal, unspecified formulation
89 http://hl7.org/fhir/sid/cvx polio, unspecified formulation
70 http://hl7.org/fhir/sid/cvx Q fever
175 http://hl7.org/fhir/sid/cvx Rabies - IM Diploid cell culture
176 http://hl7.org/fhir/sid/cvx Rabies - IM fibroblast culture
40 http://hl7.org/fhir/sid/cvx rabies, intradermal injection
18 http://hl7.org/fhir/sid/cvx rabies, intramuscular injection
90 http://hl7.org/fhir/sid/cvx rabies, unspecified formulation
72 http://hl7.org/fhir/sid/cvx rheumatic fever
159 http://hl7.org/fhir/sid/cvx Rho(D) - Unspecified formulation
157 http://hl7.org/fhir/sid/cvx Rho(D) -IG IM
156 http://hl7.org/fhir/sid/cvx Rho(D)-IG
73 http://hl7.org/fhir/sid/cvx Rift Valley fever
34 http://hl7.org/fhir/sid/cvx RIG
119 http://hl7.org/fhir/sid/cvx rotavirus, monovalent
116 http://hl7.org/fhir/sid/cvx rotavirus, pentavalent
74 http://hl7.org/fhir/sid/cvx rotavirus, tetravalent
122 http://hl7.org/fhir/sid/cvx rotavirus, unspecified formulation
71 http://hl7.org/fhir/sid/cvx RSV-IGIV
93 http://hl7.org/fhir/sid/cvx RSV-MAb
145 http://hl7.org/fhir/sid/cvx RSV-MAb (new)
06 http://hl7.org/fhir/sid/cvx rubella
38 http://hl7.org/fhir/sid/cvx rubella/mumps
76 http://hl7.org/fhir/sid/cvx Staphylococcus bacterio lysate
138 http://hl7.org/fhir/sid/cvx Td (adult)
09 http://hl7.org/fhir/sid/cvx Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
113 http://hl7.org/fhir/sid/cvx Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
139 http://hl7.org/fhir/sid/cvx Td(adult) unspecified formulation
115 http://hl7.org/fhir/sid/cvx Tdap
180 http://hl7.org/fhir/sid/cvx tetanus immune globulin
35 http://hl7.org/fhir/sid/cvx tetanus toxoid, adsorbed
142 http://hl7.org/fhir/sid/cvx tetanus toxoid, not adsorbed
112 http://hl7.org/fhir/sid/cvx tetanus toxoid, unspecified formulation
77 http://hl7.org/fhir/sid/cvx tick-borne encephalitis
13 http://hl7.org/fhir/sid/cvx TIG
98 http://hl7.org/fhir/sid/cvx TST, unspecified formulation
95 http://hl7.org/fhir/sid/cvx TST-OT tine test
96 http://hl7.org/fhir/sid/cvx TST-PPD intradermal
97 http://hl7.org/fhir/sid/cvx TST-PPD tine test
78 http://hl7.org/fhir/sid/cvx tularemia vaccine
190 http://hl7.org/fhir/sid/cvx Typhoid conjugate vaccine (TCV)
25 http://hl7.org/fhir/sid/cvx typhoid, oral
41 http://hl7.org/fhir/sid/cvx typhoid, parenteral
53 http://hl7.org/fhir/sid/cvx typhoid, parenteral, AKD (U.S. military)
91 http://hl7.org/fhir/sid/cvx typhoid, unspecified formulation
101 http://hl7.org/fhir/sid/cvx typhoid, ViCPs
131 http://hl7.org/fhir/sid/cvx typhus, historical
75 http://hl7.org/fhir/sid/cvx vaccinia (smallpox)
105 http://hl7.org/fhir/sid/cvx vaccinia (smallpox) diluted
79 http://hl7.org/fhir/sid/cvx vaccinia immune globulin
21 http://hl7.org/fhir/sid/cvx varicella
81 http://hl7.org/fhir/sid/cvx VEE, inactivated
80 http://hl7.org/fhir/sid/cvx VEE, live
92 http://hl7.org/fhir/sid/cvx VEE, unspecified formulation
36 http://hl7.org/fhir/sid/cvx VZIG
117 http://hl7.org/fhir/sid/cvx VZIG (IND)
37 http://hl7.org/fhir/sid/cvx yellow fever
183 http://hl7.org/fhir/sid/cvx Yellow fever vaccine - alt
184 http://hl7.org/fhir/sid/cvx Yellow fever, unspecified formulation
121 http://hl7.org/fhir/sid/cvx zoster live
187 http://hl7.org/fhir/sid/cvx zoster recombinant
188 http://hl7.org/fhir/sid/cvx zoster, unspecified formulation
998 http://hl7.org/fhir/sid/cvx no vaccine administered
99 http://hl7.org/fhir/sid/cvx RESERVED - do not use
999 http://hl7.org/fhir/sid/cvx unknown
AGRPAL urn:oid:1.2.36.1.2001.1005.17 Agrippal
AVAXM urn:oid:1.2.36.1.2001.1005.17 Avaxim
BCG urn:oid:1.2.36.1.2001.1005.17 BCG
CDT urn:oid:1.2.36.1.2001.1005.17 CDT
CMX urn:oid:1.2.36.1.2001.1005.17 COMVAX
DTP urn:oid:1.2.36.1.2001.1005.17 Triple Antigen
DTPA urn:oid:1.2.36.1.2001.1005.17 DTPa
ENGP urn:oid:1.2.36.1.2001.1005.17 Engerix B
FLRIX urn:oid:1.2.36.1.2001.1005.17 Fluarix
FLUVAX urn:oid:1.2.36.1.2001.1005.17 Fluvax
FLVRN urn:oid:1.2.36.1.2001.1005.17 Fluvirin
FVXJNR urn:oid:1.2.36.1.2001.1005.17 Fluvax Junior
GNDIP urn:oid:1.2.36.1.2001.1005.17 Diphtheria
GNFLU urn:oid:1.2.36.1.2001.1005.17 Influenza
GNHEP urn:oid:1.2.36.1.2001.1005.17 Hepatitis B
GNHIB urn:oid:1.2.36.1.2001.1005.17 HIB
GNHPA urn:oid:1.2.36.1.2001.1005.17 Hepatitis A
GNJEN urn:oid:1.2.36.1.2001.1005.17 Japanese Encephalitis
GNMEA urn:oid:1.2.36.1.2001.1005.17 Measles
GNMEN urn:oid:1.2.36.1.2001.1005.17 Meningococcal C
GNMUM urn:oid:1.2.36.1.2001.1005.17 Mumps
GNPNE urn:oid:1.2.36.1.2001.1005.17 Pneumococcal
GNPOL urn:oid:1.2.36.1.2001.1005.17 Polio
GNROX urn:oid:1.2.36.1.2001.1005.17 Rotavirus
GNRUB urn:oid:1.2.36.1.2001.1005.17 Rubella
GNTET urn:oid:1.2.36.1.2001.1005.17 Tetanus
GNVAR urn:oid:1.2.36.1.2001.1005.17 Varicella
HATWNJ urn:oid:1.2.36.1.2001.1005.17 Twinrix Junior
HAVAQ urn:oid:1.2.36.1.2001.1005.17 Vaqta Paed/Adol
HAVJ urn:oid:1.2.36.1.2001.1005.17 Havrix Junior
HBOC urn:oid:1.2.36.1.2001.1005.17 HibTITER
HBV urn:oid:1.2.36.1.2001.1005.17 HBV
HBVP urn:oid:1.2.36.1.2001.1005.17 HBVAX II
HBX urn:oid:1.2.36.1.2001.1005.17 Hiberix
IFHX urn:oid:1.2.36.1.2001.1005.17 Infanrix Hexa
IFIP urn:oid:1.2.36.1.2001.1005.17 Infanrix-IPV
IFPA urn:oid:1.2.36.1.2001.1005.17 Infanrix Penta
IFX urn:oid:1.2.36.1.2001.1005.17 Infanrix
IFXB urn:oid:1.2.36.1.2001.1005.17 InfanrixHepB
INFLUV urn:oid:1.2.36.1.2001.1005.17 Influvac
IPV urn:oid:1.2.36.1.2001.1005.17 IPOL
JEVAX urn:oid:1.2.36.1.2001.1005.17 JE-VAX
MENJUG urn:oid:1.2.36.1.2001.1005.17 Menjugate
MENTEC urn:oid:1.2.36.1.2001.1005.17 Meningitec
MENUME urn:oid:1.2.36.1.2001.1005.17 Menomune
MENVAX urn:oid:1.2.36.1.2001.1005.17 Mencevax ACWY
MMR urn:oid:1.2.36.1.2001.1005.17 MMR
MMRCSL urn:oid:1.2.36.1.2001.1005.17 MMR II
MMRSKB urn:oid:1.2.36.1.2001.1005.17 Priorix
MNTRX urn:oid:1.2.36.1.2001.1005.17 Menitorix
NEISVC urn:oid:1.2.36.1.2001.1005.17 NeisVac-C
OPV urn:oid:1.2.36.1.2001.1005.17 Polio
P urn:oid:1.2.36.1.2001.1005.17 Pertussis
PANVAX urn:oid:1.2.36.1.2001.1005.17 Panvax
PDCL urn:oid:1.2.36.1.2001.1005.17 Pediacel
PLCL urn:oid:1.2.36.1.2001.1005.17 Poliacel
PNEUMO urn:oid:1.2.36.1.2001.1005.17 Pneumovax
PRPD urn:oid:1.2.36.1.2001.1005.17 ProHIBit
PROQAD urn:oid:1.2.36.1.2001.1005.17 ProQuad
PRPOMP urn:oid:1.2.36.1.2001.1005.17 PedvaxHIB
PRPT urn:oid:1.2.36.1.2001.1005.17 ActHIB
PRVNR urn:oid:1.2.36.1.2001.1005.17 Prevenar 7
PRVTH urn:oid:1.2.36.1.2001.1005.17 Prevenar 13
PRXTEX urn:oid:1.2.36.1.2001.1005.17 Priorix-Tetra
QDCL urn:oid:1.2.36.1.2001.1005.17 Quadracel
ROTRIX urn:oid:1.2.36.1.2001.1005.17 Rotarix
ROTTEQ urn:oid:1.2.36.1.2001.1005.17 Rotateq
SYNFLX urn:oid:1.2.36.1.2001.1005.17 Synflorix
TCL urn:oid:1.2.36.1.2001.1005.17 Tripacel
VAXGRP urn:oid:1.2.36.1.2001.1005.17 Vaxigrip
VGRJNR urn:oid:1.2.36.1.2001.1005.17 Vaxigrip Junior
VLRIX urn:oid:1.2.36.1.2001.1005.17 Varilrix
VRVAX urn:oid:1.2.36.1.2001.1005.17 Varivax

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

Lvl A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
Display The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code